Product Information

CLINDAMYCIN HCL 150 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1048 per EA under NDC 65862018501. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Aug 26, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYCIN HCL 150 MG CAPSULE

Clindamycin Hydrochloride
$0.1048per EA

Strength

150 mg/1

NDC

65862018501

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CLINDAMYCIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA065442

FDA Approved

8/26/2009

TE Code

AB

On Market Since

8/26/2009

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYCIN HCL 150 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 15.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1048 per EA
All-time high$0.1398 (Jun 16, 2021)
All-time low$0.0760 (Nov 20, 2024)
52-week high$0.1097
52-week low$0.1018
Median price$0.1080
Average price$0.1105
Largest weekly change+26.2% (Aug 21, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.6%

1M

-0.6%

3M

-1.8%

6M

-0.0%

1Y

+2.9%

3Y

-2.4%

5Y

-22.0%

All

+15.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CLINDAMYCIN HCL 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 150 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1048 per EA (NDC 65862018501), effective Aug 19, 2026.

How has the price of CLINDAMYCIN HCL 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN HCL 150 MG CAPSULE has risen 15.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 150 MG CAPSULE?

Since Nov 28, 2013, the NADAC for CLINDAMYCIN HCL 150 MG CAPSULE has ranged from a low of $0.0760 (Nov 20, 2024) to a high of $0.1398 (Jun 16, 2021), with a median of $0.1080 per EA.

Are there cheaper alternatives to CLINDAMYCIN HCL 150 MG CAPSULE?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN HCL 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CLINDAMYCIN HCL 150 MG CAPSULE?

CLINDAMYCIN HCL 150 MG CAPSULE (NDC 65862018501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.